Autonomix Medical Files 8-K
Ticker: AMIX · Form: 8-K · Filed: Jan 22, 2025 · CIK: 1617867
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Autonomix Medical filed an 8-K on Jan 22, 2025, with Reg FD disclosures and financials.
AI Summary
Autonomix Medical, Inc. filed an 8-K on January 22, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Delaware with its principal executive offices in The Woodlands, TX, operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This filing provides important updates and financial information for Autonomix Medical, Inc., which is crucial for investors and stakeholders to understand the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically contains disclosures and financial statements without immediate significant operational or financial changes.
Key Numbers
- 001-41940 — SEC File Number (Identifies the company's filing with the SEC.)
- 47-1607810 — IRS Number (Company's Employer Identification Number.)
Key Players & Entities
- Autonomix Medical, Inc. (company) — Registrant
- January 22, 2025 (date) — Date of Report
- The Woodlands, TX (location) — Principal Executive Offices
- Delaware (location) — State of Incorporation
- 3841 (industry_code) — Standard Industrial Classification
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of this disclosure are not provided in the excerpt. The full filing would contain this information.
What are the main exhibits included with this 8-K filing?
The filing states 'Financial Statements and Exhibits' are included, but the specific list or content of these exhibits is not detailed in the provided text.
When is Autonomix Medical's fiscal year end?
Autonomix Medical's fiscal year ends on March 31st.
What is the company's primary business activity based on its SIC code?
The company's SIC code is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
What is the phone number listed for Autonomix Medical's principal executive offices?
The telephone number for Autonomix Medical's principal executive offices is (713) 588-6150.
Filing Stats: 815 words · 3 min read · ~3 pages · Grade level 11.9 · Accepted 2025-01-22 16:03:43
Key Financial Figures
- $0.001 — h Registered Common Stock , par value $0.001 per share AMIX The Nasdaq Stock Mark
Filing Documents
- amix20250121_8k.htm (8-K) — 29KB
- ex_768078.htm (EX-99.1) — 11KB
- a01.jpg (GRAPHIC) — 45KB
- a02.jpg (GRAPHIC) — 100KB
- a03.jpg (GRAPHIC) — 80KB
- a04.jpg (GRAPHIC) — 74KB
- a05.jpg (GRAPHIC) — 41KB
- a06.jpg (GRAPHIC) — 78KB
- a07.jpg (GRAPHIC) — 85KB
- a08.jpg (GRAPHIC) — 82KB
- a09.jpg (GRAPHIC) — 81KB
- a10.jpg (GRAPHIC) — 84KB
- a11.jpg (GRAPHIC) — 77KB
- a12.jpg (GRAPHIC) — 75KB
- a13.jpg (GRAPHIC) — 71KB
- a14.jpg (GRAPHIC) — 55KB
- a15.jpg (GRAPHIC) — 64KB
- a16.jpg (GRAPHIC) — 82KB
- a17.jpg (GRAPHIC) — 59KB
- a18.jpg (GRAPHIC) — 32KB
- logoa.jpg (GRAPHIC) — 2KB
- 0001437749-25-001558.txt ( ) — 1923KB
- amix-20250122.xsd (EX-101.SCH) — 3KB
- amix-20250122_def.xml (EX-101.DEF) — 12KB
- amix-20250122_lab.xml (EX-101.LAB) — 15KB
- amix-20250122_pre.xml (EX-101.PRE) — 12KB
- amix20250121_8k_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure As previously announced in a press release by Autonomix Medical, Inc. (the "Company") on January 15, 2025, the Company's Chief Executive Officer, Brad Hauser, participated in the "Virtual Investor Closing Bell Series" on January 22, 2025. A live video webcast of the event will be available on the Events page under the Investors section of the Company's website (autonomix.com). A webcast replay will be available two hours following the live event and will be accessible for 90 days. A copy of the conference presentation is attached to this report as Exhibit 99.1 and is incorporated by reference herein. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for the purpose of the Securities Exchange Act of 1934, as amended ("Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference. Some of the statements in the conference presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Forward-looking statements are identified by terminology including ''believes,'' ''estimates,'' ''anticipates,'' ''expects,'' ''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,'' ''could,'' ''might,'' ''will,'' ''should,'' ''approximately'' or other words that convey uncertainty of future events or outcomes to identify these forward-l
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit No. Exhibit 99.1 "Virtual Investor Closing Bell Series " Presentation dated January 22, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AUTONOMIX MEDICAL, INC. By: /s/ Trent Smith Trent Smith Chief Financial Officer Dated: January 22, 2025